Progression of cardiovascular autonomic neuropathy and cardiovascular disease in type 2 diabetes.
Jae-Seung YunYong-Moon ParkSeon-Ah ChaYu-Bae AhnSeung Hyun KoPublished in: Cardiovascular diabetology (2018)
CAN stage progression was associated with an increased risk of CVD in this type 2 diabetes cohort. Patients with rapid CAN progression had the greatest risk of CVD. Thus, regular screening and risk management of CAN progression is necessary to prevent CVD.